The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma
CHMP4C is highly expressed in a variety of tumors. We demonstrated that CHMP4C expression may be associated with the occurrence, development, prognosis and chemotherapy sensitivity in patients with lung adenocarcinoma. These findings may open up new research directions and development opportunities for the treatment of lung adenocarcinoma.
Authors
- Mingshan Liu (ORCID: https://orcid.org/0000-0002-0259-7248)
- Yang Li (ORCID: https://orcid.org/0000-0002-6287-5094)
- Wan Zhang (ORCID: https://orcid.org/0000-0003-1896-8186)
- Jingtao Zhang (ORCID: https://orcid.org/0000-0002-9548-7805)
- Xiaoyue Peng
- Chuan Xu (ORCID: https://orcid.org/0009-0004-0588-1780)
- Wei Zhou (ORCID: https://orcid.org/0000-0001-7534-3065)
- Bentong Yu
Institutions
- Nanchang University (CN)
- China-Japan Friendship Hospital (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiangxi Provincial People's Hospital (CN)
- Jiangxi Chest Hospital (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1007/s12672-025-01986-6
- Citations
- 3
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Health Commission of Jiangxi Province